Semiconductors are the session's dominant bullish theme. Options flow is flooding into the chip complex, with MU, NVDA, and AMD all absorbing heavy positive bets. RBC Capital meanwhile turned more bullish on mining today. The bank raised its target on NEM by $20 to $155 and lifted FCX to $85. Both upgrades came from the same analyst team on the same day — a clear sector-level call on rising metals demand.
SpaceX added $100 billion in valuation in a single day. That is more than twice Rocket Lab's entire market cap. The move is a reminder of how much private-market momentum sits outside public indices right now. is also in focus. Reports say it is targeting Walmart's biggest delivery advantage as the two retail giants escalate their logistics war.
Europe's drug regulator endorsed Novo Nordisk's hemophilia A therapy today. The EMA committee approval adds another asset to Novo's pipeline beyond GLP-1. Eli Lilly shares also moved on the news given its rivalry in the obesity and rare disease space. In a setback for the sector, Novartis halted its experimental ALS drug trial — though the company simultaneously acquired a new brain-delivery platform, signalling it is not stepping back from neurology.
Short sellers are not ignoring the rate backdrop. The SPDR Insurance ETF KIE saw short interest spike 25% in a week. Real estate is under similar pressure. Vornado Realty short interest jumped over 20% as analyst downgrades pile up. Fluence Energy dropped today after cutting guidance and seeing multiple analyst target reductions. Earnings season arrives in full force next week, with homebuilders, autoparts, and payroll processors all set to report.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
